Letrozole 2.5 mg

Introduction

LETROZONE 2.5 is a highly potent anti-estrogenic medication containing Letrozole (2.5mg). It belongs to a class of drugs known as aromatase inhibitors, widely prescribed for the treatment of hormone receptor-positive breast cancer in postmenopausal women. In addition to oncology use, Letrozole is also increasingly used in infertility treatments to induce ovulation in women suffering from PCOS (Polycystic Ovary Syndrome) or unexplained infertility.

Key Features and Ingredients

• Brand Name: LETROZONE 2.5

• Generic Name: Letrozole 2.5mg

• Drug Class: Non-steroidal aromatase inhibitor

• Type: Oral Tablet

Core Ingredient:

• Letrozole (2.5mg) – An advanced non-steroidal aromatase inhibitor that blocks the conversion of androgens to estrogens, effectively reducing circulating estrogen levels in the body.

Therapeutic Uses of LETROZONE 2.5

Oncology Use:

• Adjuvant treatment of early-stage hormone-positive breast cancer

• First-line treatment of advanced or metastatic breast cancer

• Extended adjuvant therapy after 5 years of tamoxifen

• Neoadjuvant therapy (shrink tumors before surgery)

Gynecology / Fertility Use:

• Induction of ovulation in anovulatory women, especially in cases of PCOS

• Considered an alternative to Clomiphene Citrate, with fewer side effects and better endometrial response

How LETROZONE 2.5 Works (Mechanism of Action)

Letrozole works by inhibiting the aromatase enzyme, which is responsible for converting androgens (produced by the adrenal glands) into estrogens in peripheral tissues. By reducing estrogen levels, LETROZONE 2.5 effectively:

• Slows down or stops the growth of estrogen-dependent tumors

• Helps regulate ovulation by allowing an increase in FSH (Follicle Stimulating Hormone)

Key Benefits of LETROZONE 2.5

• Targeted hormonal therapy with minimal systemic toxicity

• Improves disease-free survival in breast cancer patients

• Prevents cancer recurrence post-surgery

• Well-tolerated alternative to Tamoxifen

• Highly effective ovulation induction agent in infertility management

• Cost-effective, widely available, and trusted by oncologists and gynecologists

Dosage & Administration

Breast Cancer:

• One tablet (2.5mg) once daily, preferably at the same time each day.

• Can be taken with or without food.

Fertility Treatment:

• Typically 2.5–5 mg daily from Day 3 to Day 7 of the menstrual cycle (under specialist supervision).

Dosage should always be customized as per the physician's guidance.

Possible Side Effects

Most side effects are mild to moderate and manageable.

Common Side Effects:

• Hot flashes

• Fatigue

• Nausea

• Headache

• Joint or muscle pain

• Dizziness

Rare but Serious Effects:

• Osteoporosis with long-term use

• Cardiovascular risks (in predisposed individuals)

• Liver function impairment

Precautions and Warnings

• Not recommended during pregnancy or breastfeeding

• Regular bone density monitoring is advised for long-term users

• Use with caution in patients with liver or kidney disease

• Not suitable for premenopausal women unless prescribed for ovulation induction

Storage Information

• Store at room temperature below 25°C

• Keep away from direct sunlight and moisture

• Keep out of reach of children

Frequently Asked Questions (FAQs)

Q1. What makes LETROZONE 2.5 different from Tamoxifen?

While Tamoxifen blocks estrogen receptors, Letrozole reduces estrogen production entirely, making it more effective for postmenopausal women.

Q2. Is LETROZONE 2.5 effective for all types of breast cancer?

No, it's most effective for ER-positive (Estrogen Receptor-positive) breast cancers.

Q3. Can I take LETROZONE 2.5 during pregnancy?

No. It is strictly contraindicated in pregnancy due to potential harm to the fetus.

Q4. Does LETROZONE 2.5 cause weight gain?

Weight changes are not commonly reported, but some patients may experience fluid retention or appetite changes.

Q5. How soon can I expect results with LETROZONE 2.5 in fertility treatment?

Ovulation typically occurs within 5–10 days after the last dose, but success rates vary depending on the individual case.

Conclusion

LETROZONE 2.5 (Letrozole 2.5mg) is a clinically proven, well-tolerated, and highly recommended hormonal therapy for breast cancer and female infertility. With dual applications in oncology and gynecology, this versatile medicine continues to be a cornerstone of treatment protocols worldwide. If you're a healthcare provider or pharma distributor looking for reliable, WHO-GMP-certified Letrozole, LETROZONE 2.5 is your trusted choice.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW